Suicide gene therapy: Conversion of ethanol to acetaldehyde mediated by human beta 2 alcohol dehydrogenase

Cancer Gene Therapy

Volumn 11, Issue 12, 2004, Pages 774-781

  Savage, Philip ^a,f   Cowburn, Pam ^a   Clemens, Dahn ^b   Hurley, Thomas ^c   Laguda, Bim ^d   Martin Duque, Pilar ^d   Vassaux, Georges ^e   Lemoine, Nick R ^e  

^a VELINDRE CANCER CENTRE   (United Kingdom)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSIDAD FRANCISCO DE VITORIA   (Spain)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^f CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Acetaldehyde; Ethanol; Suicide gene

Indexed keywords

ACETALDEHYDE; ALCOHOL; ALCOHOL DEHYDROGENASE; BETA 2 ALCOHOL DEHYDROGENASE; CISPLATIN; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CARCINOMA CELL; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DAUDI CELL; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUICIDE GENE; SUICIDE GENE THERAPY; TUMOR CELL LINE;

ACETALDEHYDE; ADENOVIRIDAE; ALCOHOL DEHYDROGENASE; CELL PROLIFERATION; ETHANOL; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, TRANSGENIC, SUICIDE; HUMANS; NEOPLASMS; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

ADENOVIRIDAE; ANIMALIA;

EID: 10444290057     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700764     Document Type: Article

References (43)

1. Xu G, McLeod HL. Strageties for enzyme/prodrug cancer therapy. Clin Cancer Res. 2001;7:3314-3324.
2. Bridgewater JA, Springer CJ, Knox RJ, et al. Expression of the bacterial nitroreductase enzyme in mammalian cells renders them selectively sensitive to killing by the prodrug CB1954. Eur J Cancer. 1995;31A:2362-2370.
3. Huber BE, Austin EA, Good SS, et al. In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase. Cancer Res. 1993;53:4619-4626.
4. Greco O, Folkes LK, Wardman P, et al. Development of a novel enzyme/prodrug combination for gene therapy of cancer: horseradish peroxidase/indole-3-acetic acid. Cancer Gene Ther. 2000;7:1414-1420.
5. Moolten FL, Wells JM. Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J Natl Cancer Inst. 1990;82:297-300.
6. Chen L, Waxman DJ. Intratumoral activation and enhanced chemotherapeutic effect of oxazaphosphorines following cytochrome P-450 gene transfer: development of a combined chemotherapy/cancer gene therapy strategy. Cancer Res. 1995;55:581-589.
7. Singh NP, Khan A. Acetaldehyde: genotoxicity and cytotoxicity in human lymphocytes. Mutat Res. 1995;337: 9-17.
8. Terabayashi H, Kolber MA. The generation of cytotoxic T lymphocytes against acetaldehyde-modified syngeneic cells. Alcohol Clin Exp Res. 1990;14:893-899.
9. Higgins PJ, Borenfreund E. Incubation of rat hepatic tumor cells with ethanol and acetaldehyde in vitro: effects on growth rate, albumin secretion and cellular protein content. Digestion. 1986;34:161-168.
10. Clemens DL, Forman A, Jerrells TR, et al. Relationship between acetaldehyde levels and cell survival in ethanol-metabolizing hepatoma cells. Hepatology. 2002;35:1196-1204.
11. Clemens DL, Calisto LE, Sorrell MF, et al. Ethanol metabolism results in a G2/M cell-cycle arrest in recombinant Hep G2 cells. Hepatology. 2003;38:385-393.
12. Liang Q, Carlson EC, Borgerding AJ, et al. A transgenic model of acetaldehyde overproduction accelerates alcohol cardiomyopathy. J Pharmacol Exp Ther. 1999;291:766-772.
13. Hurley TD, Edenberg HJ, Li T-K. The pharmacogenomics of alcoholism. In: Pharmacogenomics: The Search for Individualized Therapeutics. Licinio J, Wong M-L, eds. Weinheim: Wiley-VCH; 2002: 417-442.
14. Kitson KE. Ethanol and acetaldehyde metabolism: past, present, and future. Alcohol Clin Exp Res. 1996;20:82A-92A.
15. Wickramasinghe SN, Malik F. Acetaldehyde causes a prolongation of the doubling time and an increase in the modal volume of cells in culture. Alcohol Clin Exp Res. 1986;10:350-354.
16. Koivisto T, Salaspuro M. Acetaldehyde alters proliferation, differentiation and adhesion properties of human colon adenocarcinoma cell line Caco-2. Carcinogenesis. 1998;19: 2031-2036.
17. Mapoles JE, Iwahashi M, Lucas D, et al. Acetaldehyde exposure causes growth inhibition in a Chinese hamster ovary cell line that expresses alcohol dehydrogenase. Alcohol Clin Exp Res. 1994;18:632-639.
18. Holownia A, Ledig M, Mapoles J, et al. Acetaldehyde-induced growth inhibition in cultured rat astroglial cells. Alcohol. 1996;1:93-97.
19. Zimmerman BT, Crawford GD, Dahl R, et al. Mechanisms of acetaldehyde-mediated growth inhibition: delayed cell cycle progression and induction of apoptosis. Alcohol Clin Exp Res. 1995;19:434-440.
20. Stone CL, Bosron WF, Dunn MF. Amino acid substitutions at position 47 of human beta 1 beta 1 and beta 2 beta 2 alcohol dehydrogenases affect hydride transfer and coenzyme dissociation rate constants. J Biol Chem. 1993;268: 892-899.
21. Thun MJ, Peto R, Lopez AD, et al. Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med. 1997;337:1705-1714.
22. Cordain L, Bryan ED, Melby CL, et al. Influence of moderate daily wine consumption on body weight regulation and metabolism in healthy free-living males. J Am Coll Nutr. 1997;16:134-139.
23. Watzl B, Bub A, Pretzer G, et al. Daily moderate amounts of red wine or alcohol have no effect on the immuns system of healthy men. Eur J Clin Nutr. 2004;58:40-45.
24. Xu YL, Carr LG, Bosron WF, et al. Genotyping of human alcohol dehydrogenases at the ADH2 and ADH3 loci following DNA sequence amplification. Genomics. 1988;2: 209-214.
25. He TC, Zhou S, da Costa LT, et al. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA. 1998;95:2509-2514.
26. Crow KE, Cornell NW, Veech RL. The rate of ethanol metabolism in isolated rat hepatocytes. Alcohol Clin Exp Res. 1977;1:43-50.
27. Philpott GW, Bower RJ, Parker CW. Selective iodination and cytotoxicity of tumor cells with an antibody-enzyme conjugate. Surgery. 1973;74:51-58.
28. Ganey PE, Thurman RG. Ethanol potentiates doxorubicin-induced inhibition of cell survival in cultured Chinese hamster ovary cells. Cancer Res. 1991;51:2036-2040.
29. Couch DB, Baker RC. Ethanol-enhanced cytotoxicity of alkylating agents. Alcohol Clin Exp Res. 2002;26:381-385.
30. Buttgereit P, Weineck S, Ropke G, et al. Efficient gene transfer into lymphoma cells using adenoviral vectors combined with lipofection. Cancer Gene Ther. 2000;7: 1145-1155.
31. Meskar A, Holownia A, Bardou LG, et al. Effect of acetaldehyde generated from ethanol by ADH-transfected CHO cells on their membrane fatty acid profiles. Alcohol. 1996;13:611-616.
32. Walia AS, Pruitt KM, Dillehay DL, et al. In vitro effect of acetaldehyde on cell-mediated cytotoxicity by murine spleen cells. Alcohol Clin Exp Res. 1989;13:766-771.
33. Abel EL. Behavioral teratology of alcohol (animal model studies of the fetal alcohol syndrome). In: Abel EL, ed. Fetal Alcohol Syndrome, Vol III. Animal Studies. Boca Raton, FL: CRC Press; 1982: 59-81.
34. Faulkner TP, Cantleberry SB, Watts VJ, Hussain AS. Comparative pharmacokinetics of ethanol in inbred strains of mice using doses based on total body water. Alcohol Clin Exp Res. 1990;14:82-86.
35. Livy DJ, Parnell SE, West JR. Blood ethanol concentration profiles: a comparison between rats and mice. Alcohol. 2003; 29:165-171.
36. Johnsen J, Stowell A, Morland J. Clinical responses in relation to blood acetaldehyde levels. Pharmacol Toxicol. 1992;70:41-45.
37. Jones AW, Neiman J, Hillbom M. Concentration-time profiles of ethanol and acetaldehyde in human volunteers treated with the alcohol-sensitizing drug, calcium carbimide. Br J Clin Pharmacol. 1988;25:213-221.
38. Willis MS, Klassen LW, Tuma DJ, et al. Adduction of soluble proteins with malondialdehyde-acetaldehyde (MAA) induces antibody production and enhances T-cell proliferation. Alcohol Clin Exp Res. 2002;26:94-106.
39. Willis MS, Thiele GM, Tuma DJ, et al. T cell proliferative responses to malondialdehyde-acetaldehyde haptenated protein are scavenger receptor mediated. Int Immunopharmacol. 2003;3:1381-1399.
40. Stewart SF, Vidali M, Day CP, et al. Oxidative stress as a trigger for cellular immune responses in patients with alcoholic liver disease. Hepatology. 2004;39:197-203.
41. Curiel DT. Strategies to adapt adenoviral vectors for targeted delivery. Ann NY Acad Sci. 1999;886:158-171.
42. Majumdar AS, Hughes DE, Lichtsteiner SP, et al. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters. Gene Therapy. 2001;8:568-578.
43. Brown JK, Byers T, Doyle C, et al. Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin. 2003;53:268-291.